Feature Channels

Journal Related News

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2014 5:00 PM EST

Science

Channels:

Keywords:

Some Mosquitoes Better at Carrying Malaria Than Others

Of about 450 different species of mosquitoes in the Anopheles genus, only about 60 can transmit the Plasmodium malaria parasite that is harmful to people. The team chose 16 mosquito species that are currently found in Africa, Asia, Europe, and Latin America, but evolved from the same ancestor approximately 100 million years ago.

View | Comment

Medicine

Channels:

Keywords:

The Artificial Pancreas Shown to Improve the Treatment of Type 1 Diabetes

pancreasartificiel.jpg

The world’s first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal. The external artificial pancreas improves glucose control and reduces the risk of hypoglycemia compared to conventional diabetes treatment.

View | Comment

Medicine

Channels:

Keywords:

Study: Most People with Dementia Never Have Screening

The majority of people with dementia have never seen a doctor about their memory and thinking problems, according to a new study published in the November 26, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

View | Comment

Medicine

Channels:

Keywords:

Why Do So Many Seniors with Memory Loss & Dementia Never Get Tested?

Despite clear signs that their memory and thinking abilities have gone downhill, more than half of seniors with these symptoms haven’t seen a doctor about them, a new study finds.

View | Comment

Medicine

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 2-Dec-2014 4:00 PM EST

Medicine

Channels:

Scientists Discover Why Patients Respond to a Life-Saving Melanoma Drug

RibasTumeh2.jpg

UCLA researchers have pioneered a new methodology to predict why some patients battling advanced melanoma respond well or not at all to the new breakthrough drug pembrolizumab (Keytruda).

View | Comment

Science

Channels:

Keywords:

Modeling the Past to Understand the Future of a Stronger El Nino

El Nino is not a contemporary phenomenon; it’s long been the Earth’s dominant source of year-to-year climate fluctuation. But as the climate warms and the feedbacks that drive the cycle change, researchers want to know how El Nino will respond. A team of researchers led by the University of Wisconsin’s Zhengyu Liu published the latest findings in this quest Nov. 27, 2014 in Nature.

View | Comment

Science

Channels:

Keywords:

Shaping the Future of Energy Storage with Conductive Clay

Materials scientists from Drexel University’s College of Engineering invented the clay, which is both highly conductive and can easily be molded into a variety of shapes and sizes. It represents a turn away from the rather complicated and costly processing—currently used to make materials for lithium-ion batteries and supercapacitors—and toward one that looks a bit like rolling out cookie dough with results that are even sweeter from an energy storage standpoint.

View | Comment

Medicine

Channels:

Keywords:

Protein Predicts Response to New Immunotherapy Drug

figure.PNG

The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found. The study, led by a Yale Cancer Center investigator, is described in the Nov. 27 edition of the journal Nature.

View | Comment